|
1
|
Jemal A, Bray F, Center MM, et al: Global
cancer statistics. CA Cancer J Clin. 61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel R, Desantis C and Jemal A:
Colorectal cancer statistics, 2014. CA Cancer J Clin. 64:104–117.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bindea G, Mlecnik B, Angell HK and Galon
J: The immune landscape of human tumors: Implications for cancer
immunotherapy. OncoImmunology. 3:e274562014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Goswami R and Kaplan MH: A brief history
of IL-9. J Immunol. 186:3283–3288. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Noelle RJ and Nowak EC: Cellular sources
and immune functions of interleukin-9. Nat Rev Immunol. 10:683–687.
2010. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Demoulin JB and Renauld JC: Interleukin 9
and its receptor: an overview of structure and function. Int Rev
Immunol. 16:345–364. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kearley J, Erjefalt JS, Andersson C, et
al: IL-9 governs allergen-induced mast cell numbers in the lung and
chronic remodeling of the airways. Am J Respir Crit Care Med.
183:865–875. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Steenwinckel V, Louahed J, Orabona C, et
al: IL-13 mediates in vivo IL-9 activities on lung epithelial cells
but not on hematopoietic cells. J Immunol. 178:3244–3251. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Oh CK, Raible D, Geba GP and Molfino NA:
Biology of the interleukin-9 pathway and its therapeutic potential
for the treatment of asthma. Inflamm Allergy Drug Targets.
10:180–186. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kim MS, Cho KA, Cho YJ and Woo SY: Effects
of interleukin-9 blockade on chronic airway inflammation in murine
asthma models. Allergy Asthma Immunol Res. 5:197–206. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Angkasekwinai P, Srimanote P, Wang YH, et
al: Interleukin-25 (IL-25) promotes efficient protective immunity
against Trichinella spiralis infection by enhancing the
antigen-specific IL-9 response. Infect Immun. 81:3731–3741. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Khan WI, Richard M, Akiho H, et al:
Modulation of intestinal muscle contraction by interleukin-9 (IL-9)
or IL-9 neutralization: Correlation with worm expulsion in murine
nematode infections. Infect Immun. 71:2430–2438. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li H and Rostami A: IL-9: Basic biology,
signaling pathways in CD4+ T cells and implications for
autoimmunity. J Neuroimmune Pharmacol. 5:198–209. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yang Y, Du L, Sun M, Kijlstra A and Yang
P: IFN-beta inhibits the increased expression of IL-9 during
experimental autoimmune uveoretinitis. PLoS One. 7:e485662012.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Leng RX, Pan HF, Ye DQ and Xu Y: Potential
roles of IL-9 in the pathogenesis of systemic lupus erythematosus.
Am J Clin Exp Immunol. 1:28–32. 2012.PubMed/NCBI
|
|
16
|
Li H, Nourbakhsh B, Ciric B, Zhang GX and
Rostami A: Neutralization of IL-9 ameliorates experimental
autoimmune encephalomyelitis by decreasing the effector T cell
population. J Immunol. 185:4095–4100. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Purwar R, Schlapbach C, Xiao S, et al:
Robust tumor immunity to melanoma mediated by
interleukin-9-producing T cells. Nat Med. 18:1248–1253. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Smith SE, Hoelzinger DB, Dominguez AL, Van
Snick J and Lustgarten J: Signals through 4-1BB inhibit T
regulatory cells by blocking IL-9 production enhancing antitumor
responses. Cancer Immunol Immunother. 60:1775–1787. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sun GG, Wang YD, Cui DW, Cheng YJ and Hu
WN: Epithelial membrane protein 1 negatively regulates cell growth
and metastasis in colorectal carcinoma. World J Gastroenterol.
20:4001–4010. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Cerkovnik P, Perhavec A, Zgajnar J and
Novakovic S: Optimization of an RNA isolation procedure from plasma
samples. Int J Mol Med. 20:293–300. 2007.PubMed/NCBI
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ouyang H, Shi Y, Liu Z, Feng S, et al:
Increased interleukin-9 and CD4 +IL-9+ T cells in patients with
systemic lupus erythematosus. Mol Med Rep. 7:1031–1037.
2013.PubMed/NCBI
|
|
23
|
de Vries VC, Wasiuk A, Bennett KA, et al:
Mast cell degranulation breaks peripheral tolerance. Am J
Transplant. 9:2270–2280. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Fábrega E, López-Hoyos M, San Segundo D,
et al: Interleukin-9 in stable liver transplant recipients.
Transplant Proc. 44:1536–1538. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhang J, Wang WD, Geng QR, et al: Serum
levels of interleukin-9 correlate with negative prognostic factors
in extranodal NK/T-cell lymphoma. PLoS One. 9:e946372014.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lv X, Feng L, Fang X, Jiang Y and Wang X:
Overexpression of IL-9 receptor in diffuse large B-cell lymphoma.
Int J Clin Exp Pathol. 6:911–916. 2013.PubMed/NCBI
|
|
27
|
Hamre H, Zeller B, Kanellopoulos A, et al:
Serum cytokines and chronic fatigue in adults surviving after
childhood leukemia and lymphoma. Brain Behav Immun. 30:80–87. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kobayashi H, Kumai T, Hayashi S, et al: A
naturally processed HLA-DR-bound peptide from the IL-9 receptor
alpha of HTLV-1-transformed T cells serves as a T helper epitope.
Cancer Immunol Immunother. 61:2215–2225. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Fischer M, Bijman M, Molin D, et al:
Increased serum levels of interleukin-9 correlate to negative
prognostic factors in Hodgkin's lymphoma. Leukemia. 17:2513–2516.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Hornakova T, Staerk J, Royer Y, et al:
Acute lymphoblastic leukemia-associated JAK1 mutants activate the
Janus kinase/STAT pathway via interleukin-9 receptor alpha
homodimers. J Biol Chem. 284:6773–6781. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Qiu L, Lai R, Lin Q, et al: Autocrine
release of interleukin-9 promotes Jak3-dependent survival of
ALK+ anaplastic large-cell lymphoma cells. Blood.
108:2407–2415. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Knoops L and Renauld JC: IL-9 and its
receptor: from signal transduction to tumorigenesis. Growth
Factors. 22:207–215. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Bauer JH, Liu KD, You Y, Lai SY and
Goldsmith MA: Heteromerization of the gammac chain with the
interleukin-9 receptor alpha subunit leads to STAT activation and
prevention of apoptosis. J Biol Chem. 273:9255–9260. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ye ZJ, Zhou Q, Yin W, Yuan ML, et al:
Differentiation and immune regulation of IL-9-producing
CD4+ T cells in malignant pleural effusion. Am J Respir
Crit Care Med. 186:1168–1179. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Lu Y, Hong S, Li H, et al: Th9 cells
promote antitumor immune responses in vivo. J Clin Invest.
122:4160–4171. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
36
|
Tran E, Nielsen JS, Wick DA, et al:
Polyfunctional T-cell responses are disrupted by the ovarian cancer
ascites environment and only partially restored by clinically
relevant cytokines. PLoS One. 5:e156252010. View Article : Google Scholar : PubMed/NCBI
|
